IVERIC bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of IVERIC bio generated cash of -$163,771,000, which is less than the previous year. Cash used in financing activities reached the amount of $428,905,000 last year. Net change in cash is therefore $214,857,000.
Cash Flow
| 2013 | -48.77M | -5K | 255.07M |
|---|---|---|---|
| 2014 | 111.08M | -427.81M | 145.94M |
| 2015 | -78.53M | 247.80M | 12.77M |
| 2016 | -108.59M | 13.73M | 6.93M |
| 2017 | -121.82M | 154.79M | 71K |
| 2018 | -41.91M | 0 | 6.14M |
| 2019 | -48.49M | 150K | 42.83M |
| 2020 | -66.09M | -143.81M | 150.58M |
| 2021 | -98.55M | 21.29M | 272.33M |
| 2022 | -163.77M | -50.27M | 428.90M |
ISEE Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 261.44M | 66.37M | 125.69M | 131.20M | 166.97M | 133.93M | 221.86M | 39.81M | 210.59M | 4.30M |
Operating activities | ||||||||||
Net income | -185.21M | -114.52M | -84.54M | -58.85M | 63.08M | 114.20M | -193.42M | -105.71M | -98.18M | -51.14M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 138K | 39K | 143K | 162K | 183K | 2.76M | 757K | 698K | 127K | 20K |
Stock-based compensation expense | 26.67M | 11.24M | 8.32M | 9.18M | 0 | 0 | 0 | 0 | 0 | 2.87M |
| Deferred income tax benefit | 26.67M | 11.24M | 8.32M | 9.18M | 0 | 0 | 0 | 0 | 0 | 2.87M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 3.53M | 858K | -3.42M | -960K | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | -42.80M | 31.07M | 14.25M | 3.60M | 0 |
Accounts payable | 9.98M | 64K | 7.16M | -241K | -1.68M | -4.48M | 14K | 3.31M | 4.89M | 2.37M |
Cash generated by operating activities | -163.77M | -98.55M | -66.09M | -48.49M | -41.91M | -121.82M | -108.59M | -78.53M | 111.08M | -48.77M |
Investing activities | ||||||||||
Purchases Of Investments | -231.04M | -142.82M | -143.81M | 0 | 0 | -12.01M | -72.19M | -411.56M | -597.76M | 0 |
Investments In Property Plant And Equipment | -736K | -361K | 0 | 0 | 0 | 0 | -572K | -2.61M | -1.65M | -5K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -50.27M | 21.29M | -143.81M | 150K | 0 | 154.79M | 13.73M | 247.80M | -427.81M | -5K |
Financing activities | ||||||||||
Common Stock Issued | 324.29M | 270.31M | 150.12M | 42.56M | 6.07M | 0 | 0 | 0 | 55.40M | 175.64M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.89M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.89M |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.9M |
Cash used in financing activities | 428.90M | 272.33M | 150.58M | 42.83M | 6.14M | 71K | 6.93M | 12.77M | 145.94M | 255.07M |
Net Change In Cash | 214.85M | 195.07M | -59.32M | -5.50M | -35.77M | 33.04M | -87.93M | 182.04M | -170.78M | 206.29M |
Cash at end of period | 476.30M | 261.44M | 66.37M | 125.69M | 131.20M | 166.97M | 133.93M | 221.86M | 39.81M | 210.59M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |